OM is a radio/chemotherapy related condition and it occurs frequently in patients undergoing head and neck cancer treatment. This condition is considered as ‘non severe’ for grades 0
The trial named AIM-TD (Addressing Involuntary Movements in Tardive Dyskinesia) is the company’s second pivotal clinical trial to assess SD-809 in tardive dyskinesia patients. The company intends to
Incruse is a long-acting muscarinic antagonist (LAMA), a type of bronchodilator which can relax airway muscles and improve airflow in and out of the lungs. Umeclidinium is the
The contract expansion will include the production of commercial quantities of a second BMS biologic medicine at Lonza’s mammalian manufacturing facility in Portsmouth, New Hampshire. Biologic medicines that
RST-001 is being developed as a first-in-class gene therapy application of optogenetics designed to restore vision to those affected by RP. Optogenetics refers to means of conferring light
The approval is based on demonstration of immune response, as measured by serum bactericidal activity against four serogroup B strains representative of prevalent strains in the US. The
According to the preliminary human and animal studies, Glassia may be able to treat and reduce the severity of GVHD, a life threatening complication of allogeneic stem cell
The company said that the cohort expansion comes after the initial stage of the trial confirmed that the maximum tolerated dose (MTD) of ME-344 in combination with topotecan
Bunionectomy surgery involves an incision in the top or side of the big toe joint and the removal or realignment of soft tissue and bone. Around 200-250 patients
Developed using modern recombinant technology, Flublok is the only flu vaccine that is 100% egg-free and highly purified. Flublok also contains three times more active ingredients than traditional
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.